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Edited by Gianni CesareniAbstract Cne1p, a calnexin homologue from Saccharomyces
cerevisiae, has been shown to possess a conserved P-domain and
lectin site as mammalian calnexin. The eﬀect of P-domain and
lectin site on the function of Cne1p was investigated in vitro
using recombinant P-domain, P-domain deletion mutant of
Cne1p, and lectin site mutant of Cne1ps (E181A and E398A)
The binding of monoglucosylated oligosaccharide (G1M9) with
Cne1p was clearly demonstrated using lectin site mutants. The
P-domain deletion mutant and the letcin site mutants partially
decreased the ability to suppress the aggregation of citrate
synthase (CS) and chicken egg yolk immunoglobulin at levels
diﬀerent from Cne1p. Furthermore, the P-domain deletion
mutant and the lectin site mutants decreased the ability to
enhance the refolding of CS. These results suggest that the
cooperation between the P-domain and the lectin site are
important for the complete function of Cne1p. Thus, we conclude
that P-domain in cooperation with the lectin site of Cne1p
functions as a chaperone.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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cerevisiae1. Introduction
Calnexin is a molecular chaperone in the endoplasmic re-
ticulum (ER) involved in the folding and quality control of
nascent glycoproteins through an oligosaccharide moiety,
Glc1Man9GlcNAc2, until these substrates are properly folded
or misfolded proteins have been degraded [1]. The isolation
and sequencing of calnexin cDNA for genomic clones of eu-
karyotic cells have revealed that the general structural orga-
nization of calnexin has been conserved through evolution
[2,3]. Cne1p, a homologue of calnexin in Sacchromyces cere-
visiae, is about 23% identical at amino acid level with mam-* Corresponding author: Fax: +81-83-933-5820.
E-mail address: akiokato@yamaguchi-u.ac.jp (A. Kato).
Abbreviations: Cne1p, S. cerevisiae calnexin homologue; CNX, canine
calnexin; ER, endoplasmic reticulum; GST, glutathione S-transferase;
CS, citrate synthase; IgY, chicken egg yolk immunoglobulin; SEC, size
exclusion chromatography; DP, P-domain deletion mutant of Cne1p;
E181A, point mutant of Cne1p at Glu181; E398A, point mutant of
Cne1p at Glu398
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binding capacity [2]. In addition, there is no calreticulin in
S. cerevisiae, which is a calnexin homologue and fulﬁlls the
same function as calnexin in mammalian ER lumen. To better
understand the function of the calnexin family in yeast, we
constructed recombinant Cne1p from S. cerevisiae and found
that Cne1p functions as a molecular chaperone in a manner
similar to mammalian calnexin [4].
The crystal structure of canine calnexin (CNX) has shown
that the protein consists of a P-domain and a globular lectin
domain [3]. The function of lectin domain is involved in the
binding of oligosaccharides, while P-domain is involved in the
binding of the thiol oxidoreductase ERp57 [5,6]. Recently,
two conﬂicting models, lectin-only model and dual-binding
model, have been proposed for mammalian calnexin. In the
lectin-only model, calnexin functions solely as a lectin with
cycles of glycoprotein release and rebinding through mono-
glucosylated oligosaccharide [7,8]. In the dual-binding model,
calnexin functions both as a lectin and as a classical molec-
ular chaperone [9,10]. This model proposes that calnexin
possesses a second site that binds to polypeptide-segments of
unfolded glycoproteins in addition to lectin binding. The
functional elucidation of P-domain and lectin site of Cne1p
may help to understand the molecular mechanism of calnexin
family. In the present study, we engineered the Cne1p P-
domain, the P-domain deletion mutant of Cne1p (DP), and
point mutants of Cne1p lectin site. These mutants were tested
for the ability in aggregation–suppression and refolding of
non-glycosylated or glycosylated substrates to elucidate its
chaperone function.2. Materials and methods
2.1. Materials
Restriction enzymes and T4 DNA ligase were purchased from
Takara Shuzo (Kyoto). Citrate synthase (CS), trypsin, chymotrypsin
and actinase were obtained from Sigma. Glycoamidase A was from
Seikagaku Kogyo (Tokyo). Isopropyl-1-thio-b-D-galactopyranoside
(IPTG) was purchased from Wako (Osaka). All other chemicals were
of analytical grade for biochemical use.
2.2. Construction of Cne1p and mutants
The construction of recombinant Cne1p was described previously
[4]. cDNAs for all other mutants were constructed by PCR using a
cDNA encoding Cne1p in pT7 BlueT vector as template. The fol-
lowing primers were used to prepare mutants of Cne1p.
Primer A, 50-GCCATGGGGACTTCATTGCTATCCAACGT-
TA-30;blished by Elsevier B.V. All rights reserved.
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ATTGC-30;
primer C, 50-GCCGCTCCCGCTGCCTAAAGGCGGTGTAA-
TGGGTG-30;
primer D, 50-GGGAAGCTTTGTGGTGCAATTATTGAGACC-
30;
Primer E, 50-CCATGGGGATGATTCCTGATGTTTCA- G-30;
Primer F, 50-GGGAAGCTTGTAGTATAGCGGGTTT- TC-30;
primer G, 50-GACAAGATCACACATGCATCTAAACTAAG-30;
primer H, 50-TGTGATCCTCGCGTTTTGGAGTGGAT-30;
primer I, 50-CTTAGTTTAGATGCATGTGTGATCTTGTC-30;
and primer J, 50-ATCCACTCCAAAACGCGAGGATCACA-30.
TheDP, Cne1p 20–247/381–502, was prepared by a two-step sequence
overlap extension method [11], using primers A, B, C, and D. Primers A
and D contain a NcoI site (underline) and a HindIII site (underline),
respectively. Primers B and C contain a sequence encode for a GSGSG
linker (underline). The ﬁrst two cDNA fragments (Cne1p 20–247 and
Cne1p 381–502) were prepared by PCRusing 50-primers A andB and 30-
primers C and D, respectively. Then, these two cDNA fragments were
mixed and subjected to PCR in the presence of ﬂanking primers A and
D. The P-domain, Cne1p 247–380, was prepared using primer E as the
50-primer and primer F as the 30-primer. The lectin sites mutants, in
which Glu181!Ala (E181A) Glu398!Ala (E398A), were prepared by
site-directed mutagenesis methods using 50-primers G and H and 30-
primers I and J, respectively. All of cDNA constructs were subcloned
into pT7 BlueT vector (Novagen) and sequenced on ABI 310 Genetic
Analyzer. After digestion with NcoI and HindIII, cDNAs were ligated
into pET-42b(+) (Novagen) expression vector.Fig. 1. Alignment of amino acid sequences of calnexins from S. cere-
visiae and canine (Dog). Alignment was generated by ClustalW pro-
gram. Identical residues are denoted by ‘‘*’’, conserved substitutions
are denoted by ‘‘:’’, and semi-conserved substitutions are denoted by
‘‘.’’. Predict signal peptide cleavage site of Cne1p is shown by arrow. P-
domain is shown in large open boxes, whereas P1 represent repeat
motif 1 (shaded in gray), and P2 represent repeat motif 2 (shaded in
gray). Two conserved residues L1 and L2 were also shaded in gray
according to CNX lectin site (3). TM, transmembrane region.2.3. Expression and puriﬁcation of recombinant proteins
These constructed expression plasmids were transformed into Esch-
erichia coli BL21 (DE3) cells for protein expression. Overexpression of
recombinant proteins was induced with 0.5 mM IPTG at 30 C for 4 h.
Cell pellets were harvested by centrifugation at 10 000 g for 5 min at
4 C and resuspended in 1 glutathione S-transferase (GST) binding
buﬀer (Novagen) containing 0.1% Triton X-100 and 1 mM PMSF, and
then centrifuged at 15 000 g for 20 min after sonication. Supernatants
were passed through 0.45 lm ﬁlter before being applied to GST binding
column (Novagen). Proteins were eluted with 10 mM reduced gluta-
thione, according to the manufacturer’s protocol (Novagen). Samples
were further puriﬁed by Sephadex G-75 gel ﬁltration (Pharmacia) and
concentrated using a Centriplus YM-50 concentrator (Millipore). Pro-
tein concentrations were determined by the Lowry method [12].Fig. 2. A schematic representation of the Cne1p constructs in this
study. Cne1p is the full-length construct; P-domain is P-domain alone
construct; DP is P-domain deletion mutation construct; E181A and
E398A are two of point mutation constructs in putative lectin site.2.4. Preparation of monoglucosylated oligosaccharide (G1M9)
Fluorescently labeled G1M9 was prepared from chicken egg im-
munoglobulin (IgY) with a method provided by Dr. Kato (Nagoya
City University). IgY was dissolved in 10 mM Tris–HCl buﬀer (pH 8.0)
and heated at 100 C for 10 min. Oligosaccharides were released from
IgY by sequential digestion with trypsin, chymotrypsin, glycoamidase
A and actinase. The oligosaccharide fractions were collected after
Dowex 50W-X8(H+) (Sigma) and Amberlite (Sigma) column. Pyr-
idylamino derivatization of oligosaccharides was reductively aminated
with 2-aminopyridine and dimethylamine-borane and puriﬁed by gel
ﬁltration on a Sephadex G-15 column. G1M9 was further puriﬁed
from pyridylamino-oligosaccharides with a TSK-gel Amide-80 column
(0.46 25 cm) using high-performance liquid chromatography system
(Hitachi), equipped with two pumps (L-6000) and a ﬂuorescence
detector (L-7485).
2.5. SDS–polyacrylamide gel electrophoresis
SDS–polyacrylamide gel electrophoresis was conducted according
to Laemmli [13] using a 12% acrylamide separating gel and a 5%
stacking gel containing 1% SDS. Electrophoresis was carried out at a
constant current of 20 mA using Tris–Glycine buﬀer containing 0.1%
SDS. After electrophoresis, the gel sheets were stained for protein
with a 0.025% Coomassie Brilliant Blue R-250 solution.
2.6. Oligosaccharide binding assay
Oligosaccharide binding to GST-fused Cne1p proteins was per-
formed by incubation of 1 lM Cne1ps with 5 lMG1M9 for 30 min at25 C in 50 mM Tris–HCl buﬀer (pH 8.0). The interaction of Cne1p
with oligosaccharide was analyzed by size-exclusion chromatography
(SEC) using a TSK-gel G3000SW column in TS buﬀer (50 mM Tris–
HCl, pH 8.0 and 0.2 M NaCl). The eluate was detected by ﬂuorescence
using excitation and emission wavelengths of 320 and 400 nm, re-
spectively. Oligosaccharide binding is expressed as a percentage of the
Fig. 3. SDS-PAGE patterns of Cne1ps puriﬁed from the soluble cell
extract. The gel sheet was stained with Coomassie brilliant blue R250.
Lane M, molecular weight marker proteins; lane 1, GST-Cne1p; lane
2, GST-P-domain; lane 3, GST-DP; lane 4, GST-E181A; lane 5, GST-
E398A.
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binding for GST.
2.7. Citrate synthase activity assay
The enzymatic activity of CS was monitored as described [14]. CS
was mixed with a reaction solution (50 mM Tris–HCl, pH 8.0, 2 mMFig. 4. Estimation of oligosaccharide binding capacity with Cne1ps by size ex
5 lMG1M9 for 30 min at 25 C in 50 mM Tris–HCl buﬀer (pH 8.0). Eluates
detected by ﬂuorescence using excitation and emission wavelengths of 320 a
percentage of the speciﬁc binding observed for GST-Cne1p after subtraction
three replicate experiments.EDTA, 10 mM oxaloacetate, 20 mM DTNB and 5 mM acetyl-CoA)
in a cuvette and then the increase in absorbance at 412 nm was
measured for 60 s using a spectrophotometer U-2001 (Hitachi, Ja-
pan). The enzymatic activity was calculated from the increase in the
absorbance.2.8. Aggregation assay
0.2 lM CS in 40 mM HEPES-KOH, pH 7.5, was mixed with
GST or GST fusion proteins in a total volume of 1 ml and heated to
45 C. Aggregation was monitored with a ﬂuorescence spectropho-
tometer 650-10-S (Hitachi, Japan). The excitation and emission
wavelengths were both set to 500 nm, and both slits were set to
2 nm.
IgY (10 mg/ml) was denatured with 0.1 M Tris–HCl (pH8.0), 6 M
guanidine–HCl and 40 mM dithiothreitol for 2 h at room temperature.
The denatured proteins were diluted 200-fold into 10 mM Tris–HCl
amd 0.15 M NaCl in the absence and presence of GST or GST fusion
proteins in a total volume of 1 ml. Protein aggregation was initiated by
incubating the sample at 44 C. Aggregation was monitored by a
ﬂuorescence spectrophotometer 650-10-S (Hitachi, Japan). The exci-
tation and emission wavelengths were both set to 360 nm, and both
slits were set to 2 nm.2.9. Reactivation of thermally inactivated citrate synthase
Reactivation experiment for CS was carried out as described
[4]. 0.8 lM CS was thermally inactivated in 50 mM Tris–HCl
buﬀer (pH 8.0) at 43 C for 30 min. Reactivation was initiated by
4-fold dilution with the same buﬀer in the absence and presence
of GST or GST fusion proteins at 25 C. The activity of the
reactivated CS was assayed spectrophotometrically at various time
points.clusion chromatography. (A) 1 lMGST or Cne1ps was incubated with
separated by SEC using a TSK-gel G3000SW column in TS buﬀer were
nd 400 nm, respectively. (B) Oligosaccharide binding is expressed as a
of control binding for GST. Error bars represent the standard error in
Fig. 5. Aggregation–suppression of a non-glycosylated and a glycosylated substrate by Cne1ps. (A) CS (0.2 lM) was incubated at 45 C in the
absence (d), or presence of 0.2 lMGST (r), or 0.2 lM Cne1p (m). Aggregation was measured by monitoring light scattering at 500 nm for 30 min.
(B) The values of light scattering at 30 min for 0.2 lM CS incubated at 45 C in the presence of 0.2 lM GST-Cne1p or GST-fused mutants were
compared to that obtained in the absence of GST-Cne1p. Error bars represent the standard error in three replicate experiments. (C) Chemically
denatured IgY was rapidly diluted to a 0.3 lMwith buﬀer in the absence (d), or presence of 0.3 lMGST (r), or 0.3 lMCne1p (m). Aggregation was
monitored by measuring light scattering at 360 nm for 30 min at 44 C. D, The values of light scattering at 30 min for 0.3 lM IgY incubated at 44 C
in the presence of 0.3 M GST-Cne1p or GST-fused mutants were compared to that obtained in the absence of GST-Cne1p. Error bars represent the
standard error in three replicate experiments.
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3.1. Construction, expression, and puriﬁcation of GST fusion
proteins
To address the position of P-domain and lectin site of
Cne1p, the amino acid sequence alignment of Cne1p and CNX
was shown in Fig. 1. The P-domain of CNX comprises resi-
dues 276–409 containing four copies each of two diﬀerent
proline-rich sequence motifs (P1 and P2). The residues 247–380
in Cne1p are highly conserved when compared with that of P-
domain in CNX, containing four copies each of two diﬀerent
proline-rich sequence motifs (P1 and P2). Thus, the putative P-
domain of Cne1p was identiﬁed as the residues 247–380. On
the other hand, the putative lectin site of CNX is composed of
six residues, including Y165, K167, Y186, M189, E217 and
E426. The last two residues are strictly conserved in the caln-
exin family [3,15]. We found that residues E181 and E398 in
Cne1p correspond to E217 and E426 in CNX, respectively. On
the basis of this alignment search, the P-domain, the DP, and
two of the point mutants (E181A and E398A) at the Cne1p
lectin site were constructed to evaluate the contribution of P-
domain and the lectin site to molecular chaperone function of
Cne1p. The schematic representation is shown in Fig. 2. These
mutants were expressed as a GST fusion form in E. coli and
puriﬁed from the soluble cell extract by GST binding aﬃnitycolumn followed by Sephadex G-75 gel ﬁltration. All re-
combinant proteins exhibited purity greater than 90% by SDS–
PAGE (Fig. 3).3.2. Lectin site mutants of Cne1p are impaired in
oligosaccharide binding
To examine whether the lectin–oligosaccharide interaction
was impaired in lectin site mutants, the binding capacity of
Cne1ps to oligosaccharide (G1M9) was estimated by SEC
(Fig. 4). The peak of GST-Cne1p-G1M9 complex was greatly
decreased by lectin site mutants, E181A and E398A. Thus, it
was conﬁrmed that point mutation of residues at the lectin site
of Cne1p dramatically lowered the binding to oligosaccha-
rides, indicating that these mutants impaired the lectin–oligo-
saccharides interaction. These ﬁndings are consistent with
previous studies on the point mutation of the lectin site in
CNX that dropped the oligosaccharide binding [15].3.3. P-domain mutants and lectin site mutants exhibit distinct
ability to suppress the aggregation of non-glycosylated
citrate synthase and glycosylated IgY
To assess whether various mutants aﬀect the aggregation–
suppression of proteins, we tested the eﬀects on non-
glycosylated CS and glycosylated IgY. CS is a common
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with molecular chaperones [16,17]. IgY containing 27.1%
monoglucosylated oligosaccharides (Glc1Man7–9GlcNAC2)
[18], has been used as a glycosylated substrate in aggrega-
tion–suppression experiments of calreticulin [19]. As shown
in Fig. 5, panels A and C, GST had no eﬀect on both CS
and IgY aggregation, whereas the aggregation was eﬀectively
suppressed in the presence of equimolar GST-Cne1p. When
tested at a Cne1p:substrate ratio of 1:1, P-domain had little
eﬀect on suppressing the aggregation of CS and IgY, but the
P-domain deletion mutant and the lectin site mutants ex-
hibited a partially decreased aggregation–suppression of CS
and IgY. The residual aggregation percentage of P-domain
deletion mutant is 70 for CS and 40 for IgY. This suggests
that the P-domain deletion mutant was more eﬀective at
suppressing the aggregation of CS than IgY. On the other
hand, the residual aggregation percentage of lectin site mu-
tants is about 35 for CS and 80 for IgY. This suggests that
the lectin site mutants, E181A and E398A, were more ef-
fective in suppressing the aggregation of IgY than CS. Ad-
ditionally, the ability of the P-domain mutant and lectin site
mutants to aggregation-suppression of CS and IgY was in-
creased at a Cne1p:substrate ratio of 2:1 (data not shown).
These results suggest that the P-domain of Cne1p cooperatesFig. 6. Reactivation of thermally denatured CS by Cne1ps. (A) CS (0.8
lM) in 50 mM Tris–HCl buﬀer (pH 8.0) was thermally inactivated by
incubation at 43 C for 30 min. Reactivation of inactivated CS was
initiated by 4-fold dilution with the same buﬀer in the absence (d), or
presence of 0.2 lM GST (r), or 0.2 lM Cne1p (m) at 25 C. CS ac-
tivity was assayed at various time points up to 60 min. (B) The values
of CS activity at 60 min for reactivation of inactivated CS at 25 C in
the presence of 0.2 lM GST-Cne1p or GST-fused mutants were
compared to that obtained in the absence of GST-Cne1p. Error bars
represent the standard error in three replicate experiments.with the lectin site in the polypeptide-based interaction and
lectin–oligosaccharide interaction.3.4. P-domain mutants and lectin site mutants retain distinct
ability to enhance the refolding of thermally denatured
citrate synthase
To investigate whether various mutants retain the addi-
tional molecular chaperone function, we tested the ability to
enhance the refolding of unfolded proteins. We have shown
that Cne1p eﬀectively enhanced the reactivation of thermal
denatured CS in a molar ratio-dependent manner [4]. As
shown in Fig. 6, panel A, the reactivation of CS was en-
hanced in the presence of equimolar GST-Cne1p after
60 min. All mutants partially retained the ability to enhance
the refolding of thermally denatured CS at levels diﬀerent
from Cne1p except P-domain (panel B). Although P-domain
alone was unable to enhance the refolding of thermally de-
natured CS, the P-domain deletion mutant apparently de-
creased the ability to enhance the refolding of thermally
denatured CS. In addition, the lectin site mutants also par-
tially decreased the ability to enhance the refolding of de-
natured CS. Thus, these results suggest that the cooperation
between the P-domain and the lectin site are important for
the complete function of Cne1p.4. Discussion
At the present stage of calnexin research, there has been
ongoing debate concerning the molecular mechanism of
chaperone function. We have reported the molecular chaper-
one function of Cne1p by estimating the ability to prevent the
aggregation and to enhance the refolding of protein substrate
in vitro [4]. The present study demonstrated that Cne1p con-
sists of a structurally conserved P-domain and lectin site in a
manner similar to mammalian calnexin. The elucidation of
individual function of P-domain and lectin site in Cne1p may
help to understand the molecular chaperone function of the
calnexin family.
The P-domain of Cne1p was incapable of suppressing the
aggregation of non-glycosylated CS and glycosylated IgY.
This ﬁnding is consistent in that the P-domain of CNX was
unable to suppress aggregation of non-glycosylated CS and
MDH [20]. This demonstrates that the function of P-domain
was evolutionarily conserved. It is probable that the P-domain
of Cne1p is involved in the interaction with an ERp57 ho-
mologue in yeast as the P-domain of CNX. In addition, we
found that the lectin site is functionally conserved. Cne1p
showed the ability to bind oligosaccharide and this ability was
impaired in lectin site mutants. Therefore, the P-domain and
the lectin site are important to the chaperone function of
Cne1p. Not only did the P-domain deletion mutant of Cne1p
decrease the ability to suppress the aggregation and to enhance
the refolding of CS and IgY, but also point mutants of the
lectin site (E181A and E398A) decreased the ability to suppress
the aggregation and to enhance the refolding of CS and IgY.
Thus, we conclude that the P-domain and the lectin site of
Cne1p cooperatively function as a molecular chaperone. These
results also support the dual model of interaction between
calnexin and substrate.
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